Citation Impact
Citing Papers
Phase III Randomized Trial of Cisplatin Plus Placebo Compared With Cisplatin Plus Cetuximab in Metastatic/Recurrent Head and Neck Cancer: An Eastern Cooperative Oncology Group Study
2005
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Untangling the ErbB signalling network
2001 Standout
Gastric cancer
2016 Standout
Combination of EGFR, HER-2/neu, and HER-3 is a stronger predictor for the outcome of oral squamous cell carcinoma than any individual family members.
1999
Nasopharyngeal carcinoma
2005 Standout
EGFR Antagonists in Cancer Treatment
2008 Standout
The Surgical Management of Oral Cancer
2006
Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial
1999
Primary chemotherapy followed by anterior craniofacial resection and radiotherapy for paranasal cancer
2003
Postoperative Irradiation with or without Concomitant Chemotherapy for Locally Advanced Head and Neck Cancer
2004 Standout
Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer
2006 Standout
K-ras Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer
2008 Standout
Thyroid cancer
2016 Standout
Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose
2008 Standout
The role of porphyrin chemistry in tumor imaging and photodynamic therapy
2010 Standout
Cisplatin resistance in human cancers
1991
Epidermal growth factor-related peptides and their receptors in human malignancies
1995 Standout
Clavilactones, a novel class of tyrosine kinase inhibitors of fungal origin
2000
Prognostic value of the BRAF V600E mutation in papillary thyroid carcinoma
2013
A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic Cancer
2004 Standout
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer
2005 Standout
Lung Cancer
2008 Standout
Comparison of Molecular Markers of Hypoxia and Imaging with 60Cu-ATSM in Cancer of the Uterine Cervix
2007
Head and neck cancer
2008 Standout
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
2006 Standout
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2014 Standout
Hyperfractionated Irradiation with or without Concurrent Chemotherapy for Locally Advanced Head and Neck Cancer
1998 Standout
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
2004 Standout
Point-of-Care Ultrasonography
2011 Standout
Concurrent Chemotherapy and Radiotherapy for Organ Preservation in Advanced Laryngeal Cancer
2003 Standout
Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck
2004 Standout
The prognostic value of epidermal growth factor receptor is related to tumor differentiation and the overall treatment time of radiotherapy in squamous cell carcinomas of the head and neck
2004
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
2005 Standout
Epidermal growth factor receptor (EGFR) as a target in cancer therapy: understanding the role of receptor expression and other molecular determinants that could influence the response to anti-EGFR drugs
2003
Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data
2009
Chemotherapy in locally advanced head and neck cancer: a critical reappraisal
1995
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
2010 Standout
mTHPC‐mediated photodynamic therapy in patients with advanced, incurable head and neck cancer: a multicenter study of 128 patients
2004
Capecitabine: A review
2005
Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer
2015 Standout
An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer
1995
Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review
2003 Standout
EGFR in colorectal cancer: more than a simple receptor
2006
Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer
2007 Standout
Head and Neck Cancer
1993 Standout
End points for new agents in induction chemotherapy for locally advanced head and neck cancers
2002
The effect of interruptions and prolonged treatment time in radiotherapy for nasopharyngeal carcinoma
1997
Laryngeal preservation in head and neck cancer: multidisciplinary approach
2006
Cisplatin and Adriamycin Resistance Are Associated with MutLα and Mismatch Repair Deficiency in an Ovarian Tumor Cell Line
1996 StandoutNobel
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2020 Standout
Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy
2017 Standout
Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer
2003
Epidermal growth factor receptor polymorphisms and clinical outcomes in non-small-cell lung cancer patients treated with gefitinib
2007
Superparamagnetic Iron Oxide–enhanced MR Imaging of Head and Neck Lymph Nodes
2002
Role of Thyroglobulin Measurement in Fine-Needle Aspiration Biopsies of Cervical Lymph Nodes in Patients with Differentiated Thyroid Cancer
1999
Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma?
2002
Antitumor activity of the selective epidermal growth factor receptor‐tyrosine kinase inhibitor (EGFR‐TKI) Iressa® (ZD1839) in an EGFR‐expressing multidrug‐resistant cell line in vitro and in vivo
2001
Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer
2008 Standout
Levels of TGF-α and EGFR Protein in Head and Neck Squamous Cell Carcinoma and Patient Survival
1998 Standout
Head and Neck Cancer
2001 Standout
Epidermal growth factor receptor expression in primary laryngeal cancer: An independent prognostic factor of neck node relapse
1999
Quadruplex DNA: sequence, topology and structure
2006 Standout
Gender differences in drug responses
2006
Controversies in the Management of Oropharynx Cancer
2008
A Systematic Review and Meta-Analysis of Prophylactic Central Neck Dissection on Short-Term Locoregional Recurrence in Papillary Thyroid Carcinoma After Total Thyroidectomy
2013
Phase I and Pharmacokinetic Study of the Oral Fluoropyrimidine S-1 on a Once-Daily-for-28-Day Schedule in Patients with Advanced Malignancies
2004
Biochemical Modulation of Cisplatin Mechanisms of Action: Enhancement of Antitumor Activity and Circumvention of Drug Resistance
2003 Standout
Phase II Multicenter Study of the Epidermal Growth Factor Receptor Antibody Cetuximab and Cisplatin for Recurrent and Refractory Squamous Cell Carcinoma of the Head and Neck
2005
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Natural Product Synthesis Using Multicomponent Reaction Strategies
2009 Standout
Head and Neck Cancer
2020 Standout
Policy: NIH to balance sex in cell and animal studies
2014 StandoutNature
Insights into Mechanisms of Cisplatin Resistance and Potential for Its Clinical Reversal
1996
Concurrent Cetuximab, Cisplatin, and Concomitant Boost Radiotherapy for Locoregionally Advanced, Squamous Cell Head and Neck Cancer: A Pilot Phase II Study of a New Combined-Modality Paradigm
2006
Surface-Enhanced Raman Spectroscopy for Bioanalysis: Reliability and Challenges
2018 Standout
Targeting signal transducer and activator of transcription 3 with G-quartet oligonucleotides: a potential novel therapy for head and neck cancer
2006
Fluorescence Lifetime Measurements and Biological Imaging
2010 Standout
Functional Nanomaterials for Phototherapies of Cancer
2014 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Real-time ultrasonography in the otolaryngology office setting
1993
Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassays in human breast tumor cytosols.
1989
A New Nanotechnology Technique for Determining Drug Efficacy Using Targeted Plasmonically Enhanced Single Cell Imaging Spectroscopy
2013
The Expanding Role of Systemic Therapy in Head and Neck Cancer
2004
Structure, Recognition, and Processing of Cisplatin−DNA Adducts
1999 Standout
Multicenter Phase II Study of Erlotinib, an Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck
2003
Molecular Genetics of Head and Neck Cancer
2002
Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data
2000 Standout
Self-Assembly Synthesis, Tumor Cell Targeting, and Photothermal Capabilities of Antibody-Coated Indocyanine Green Nanocapsules
2010
p53 Alterations Predict Tumor Response to Neoadjuvant Chemotherapy in Head and Neck Squamous Cell Carcinoma: A Prospective Series
2000
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Prognostic Value of an Activation State Marker for Epidermal Growth Factor Receptor in Tissue Microarrays of Head and Neck Cancer
2006
Prognostic Significance of Vascular Endothelial Growth Factor Protein Levels in Oral and Oropharyngeal Squamous Cell Carcinoma
2000
Correlation between Development of Rash and Efficacy in Patients Treated with the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Erlotinib in Two Large Phase III Studies
2007
Induction Chemotherapy plus Radiation Compared with Surgery plus Radiation in Patients with Advanced Laryngeal Cancer
1991 Standout
EGFR, p16, HPV Titer, Bcl-xL and p53, Sex, and Smoking As Indicators of Response to Therapy and Survival in Oropharyngeal Cancer
2008
Efficacy of the Oral Fluorouracil Pro-drug Capecitabine in Cancer Treatment: a Review
2008
The Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor
1995
Works of F Démard being referenced
Dose reduction without loss of efficacy for 5-fluorouracil and cisplatin combined with folinic acid. In vitro study on human head and neck carcinoma cell lines
1991
Phase II trial of cisplatin, fluorouracil, and pure folinic acid for locally advanced head and neck cancer: a pharmacokinetic and clinical survey.
1995
Response to chemotherapy as justification for modification of the therapeutic strategy for pharyngolaryngeal carcinomas
1990
Characterization, quantification, and potential clinical value of the epidermal growth factor receptor in head and neck squamous cell carcinomas
1991
Prognostic impact of the epidermal growth factor receptor levels for patients with larynx and hypopharynx cancer
2005
Prognostic value of continuous variables in breast cancer and head and neck cancer. Dependence on the cut-off level
1988
Population study of dihydropyrimidine dehydrogenase in cancer patients.
1994
Dihydropyrimidine dehydrogenase activity in cancer patients
1993
Relationship between fluorouracil systemic exposure and tumor response and patient survival.
1994
Influence of sex and age on fluorouracil clearance.
1992
Response to fluorouracil therapy in cancer patients: the role of tumoral dihydropyrimidine dehydrogenase activity.
1995
Clinical impact of cervical lymph node involvement and central neck dissection in patients with papillary thyroid carcinoma: a retrospective analysis of 368 cases
2011
Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer.
1993
Analysis of the dinucleotide repeat polymorphism in the epidermal growth factor receptor (EGFR) gene in head and neck cancer patients
2005
Is routine triple endoscopy for head and neck carcinoma patients necessary in light of a negative chest computed tomography scan?
2004
The relationship of epidermal growth factor receptor levels to the prognosis of unresectable pharyngeal cancer patients treated by chemo-radiotherapy
2001
Low-energy He/Ne laser in the prevention of radiation-induced mucositis
1999
Induction chemotherapy with cis-platinum and 5-fluorouracil for squamous cell carcinoma of the head and neck
1986
Chemotherapy- and radiotherapy-induced mucositis in head and neck cancer patients: new trends in pathophysiology, prevention and treatment
2001
Ear, nose, and throat cancer: ultrasound diagnosis of metastasis to cervical lymph nodes.
1984
A randomized EORTC study on the effect of preoperative polychemotherapy in pyriform sinus carcinoma treated by pharyngolaryngectomy and irradiation. Results from 5 to 10 years.
1990